- Home
- RLMD vs SOL Comparison
RLMD vs SOL Comparison
Compare RLMD & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- SOL
- Stock Information
- Founded
- RLMD 2004
- SOL 2005
- Country
- RLMD United States
- SOL United States
- Employees
- RLMD N/A
- SOL N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- RLMD Health Care
- SOL Technology
- Exchange
- RLMD Nasdaq
- SOL Nasdaq
- Market Cap
- RLMD 110.6M
- SOL 109.2M
- IPO Year
- RLMD N/A
- SOL 2008
- Fundamental
- Price
- RLMD $3.16
- SOL $2.03
- Analyst Decision
- RLMD Hold
- SOL Buy
- Analyst Count
- RLMD 2
- SOL 3
- Target Price
- RLMD $7.50
- SOL $3.83
- AVG Volume (30 Days)
- RLMD 110.4K
- SOL 204.9K
- Earning Date
- RLMD 11-07-2024
- SOL 11-14-2024
- Dividend Yield
- RLMD N/A
- SOL N/A
- EPS Growth
- RLMD N/A
- SOL N/A
- EPS
- RLMD N/A
- SOL N/A
- Revenue
- RLMD N/A
- SOL $103,577,000.00
- Revenue This Year
- RLMD N/A
- SOL $44.70
- Revenue Next Year
- RLMD N/A
- SOL $20.53
- P/E Ratio
- RLMD N/A
- SOL N/A
- Revenue Growth
- RLMD N/A
- SOL 7.56
- 52 Week Low
- RLMD $1.88
- SOL $1.41
- 52 Week High
- RLMD $7.22
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- RLMD 39.24
- SOL 35.58
- Support Level
- RLMD $3.06
- SOL $2.00
- Resistance Level
- RLMD $3.43
- SOL $2.18
- Average True Range (ATR)
- RLMD 0.20
- SOL 0.15
- MACD
- RLMD -0.04
- SOL -0.05
- Stochastic Oscillator
- RLMD 16.30
- SOL 4.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.